Global Cord Blood (NYSE:CO) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

Global Cord Blood Co. (NYSE:COGet Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.96 and traded as high as $1.00. Global Cord Blood shares last traded at $1.00, with a volume of 164 shares traded.

Global Cord Blood Trading Up 5.3%

The company has a 50-day moving average price of $0.99 and a two-hundred day moving average price of $0.96. The stock has a market capitalization of $121.55 million, a P/E ratio of 1.56 and a beta of 0.16.

About Global Cord Blood

(Get Free Report)

Global Cord Blood Corporation (NYSE: CO) is a leading operator of umbilical cord blood banking services in the People’s Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.

In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.

See Also

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.